NeuroPace, Inc. logo

NPCENeuroPace, Inc.

NPCE Stock Price, Valuation & Chart | NeuroPace, Inc.

Compare

NPCE Historical price chart

NPCE Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization517.88M
PE Ratio-26.65
EPS-0.57
Trading Volume163.71K
Today's High/Low15.55/14.75
Dividend Yield0.00
52 Week High/Low19.6/8.88
Shares Outstanding34.09M
NPCE Financial Statement
NPCE Analyst ratings
NPCE Analysis & performance metrics

NPCE Company profile

NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically…

NPCE Management team

Management
Katie Keller
Vice President of Marketing
Leah Akin
General Counsel & Corporate Secretary
Martha J. Morrell M.D.
Chief Medical Officer
Amy Treadwell
Vice President of Human Resources
Kelley Nicholas
Vice President of Sales
Dylan St. John
Chief of Operations & Development
Rebecca L. KuhnCFO
Chief Financial Officer and Vice President of Finance & Administration
Joel D. BeckerCEO
Chief Executive Officer, President & Director
Total 8 executives

NPCE Frequently asked questions

What is NeuroPace, Inc. (NPCE) Stock Price?

Current stock price of NeuroPace, Inc. (NPCE) stock is $15.190. The stock price is +3.05% higher in the session. The intraday range can be seen from this page. Volume of NeuroPace, Inc. (NPCE) stock is 163.71K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the NeuroPace, Inc. (NPCE) stock price going up or down today?

The stock price of NeuroPace, Inc. (NPCE) can change with earnings, company news, and overall market sentiment. NeuroPace, Inc. operates in the Healthcare / Medical - Devices market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the NeuroPace, Inc. stock expensive at its current price?

Whether NeuroPace, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for NPCE on this page is -26.65. EPS on this page is -0.57. Compare those figures with peers and growth expectations before deciding if the current NeuroPace, Inc. price is justified.

How has the stock price of NeuroPace, Inc. (NPCE) performed historically?

Historical performance for NeuroPace, Inc. (NPCE) is shown on the price chart on this page. Review multi-period moves alongside volume to see how NPCE reacted to past earnings and market events.

Should I buy NeuroPace, Inc. (NPCE) stock, at this price?

Buying NeuroPace, Inc. (NPCE) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.